Humana Inc（HUM）财务数据HUMHumana Inc

Humana Inc. (HUM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Premiums, accounting for 95.0% of total sales, equivalent to $38.83B. Other significant revenue streams include Service and Investment income. Understanding this composition is critical for investors evaluating how HUM navigates market cycles within the Managed Healthcare industry.

Evaluating the bottom line, Humana Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.52%, while the net margin is 1.70%. These profitability ratios, combined with a Return on Equity (ROE) of 6.83%, provide a clear picture of how effectively HUM converts its operational activities into shareholder value.

In the context of the broader market, HUM competes directly with industry leaders such as CNC and CI. With a market capitalization of $46.72B, it holds a significant position in the sector. When comparing efficiency, HUM's gross margin of N/A stands against CNC's N/A and CI's 8.58%. Such benchmarking helps identify whether Humana Inc. is trading at a premium or discount relative to its financial performance.

Humana's revenue has shown consistent growth, with Q2 2026 revenue at $40.87 billion, up from $32.31 billion in Q1 2025. However, net income has fluctuated, with a recent Q2 2026 net income of $694 million, down from $1.19 billion in Q1 2026.